Fingerprint
Dive into the research topics of 'Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: Safety and pharmacokinetics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: Safety and pharmacokinetics
Michael A. Carducci, Joel B. Nelson, M. Kathy Bowling, Theresa Rogers, Mario A. Eisenberger, Victoria Sinibaldi, Ross Donehower, Terri L. Leahy, Robert A. Carr, Jeffrey D. Isaacson, Todd J. Janus, Amy Andre, Balakrishna S. Hosmane, Robert J. Padley
Research output: Contribution to journal › Article › peer-review
156
Scopus
citations